SCHEMBL23155362

SCHEMBL23155362

c1ccc(N(c2ccc3c(c2)-c2c4cccc2-c2cccc-3c2-c2ccccc2-4)c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.39
▸ MEN1 O00255 5/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ALOX5 P09917 2/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ PLK3 Q9H4B4 1/20 0.35
▸ PTGER4 P35408 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ TTR P02766 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155354 0.94 MEN1 (0.37) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155122 0.93 MMP12 (0.35) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155370 0.92 MAPT (0.39) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155313 0.90 MEN1 (0.36) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155244 0.89 AHR (0.36) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155227 0.87 MEN1 (0.35) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155330 0.86 NPC1 (0.36) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL21141069 0.86 AHR (0.47) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL25580701 0.86 AHR (0.38) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL23155169 0.85 DUSP3 (0.36) AHRMEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 AHR 1479/4885MEN1 1466/4885KMT2A 2708/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 AHR 1479/4885MEN1 1466/4885KMT2A 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback